Skip to main content
. 2020 May 23;35(2):562–572. doi: 10.1038/s41375-020-0868-z

Fig. 2. Overall survival.

Fig. 2

Patients with eGFR <60 mL/min/1.73 m² (a), <45 mL/min/1.73 m² (b) and ≥60 mL/min/1.73 m² (c) in the Isa-Pd and Pd arms. CI confidence interval, eGFR estimated glomerular filtration rate, HR hazard ratio, Isa-Pd isatuximab, pomalidomide, and dexamethasone, OS overall survival, Pd pomalidomide and dexamethasone, NR not reached.